通过PROTAC介导的降解来解决Fak的激酶独立功能
Philipp M Cromm1, Kusal T G Samarasinghe1, John Hines1
1Department of Molecular, Cellular & Developmental Biology , Yale University , New Haven , Connecticut 06511 , United States.
通过小分子诱导的蛋白质降解提供了一种新的治疗策略. 一种新型的焦点粘附激酶 (FAK) 降解剂PROTAC-3有效抑制瘤细胞迁移和入侵,其性能优于现有的抑制剂.
科学领域:
- 生物化学
- 分子生物学
- 癌症学
背景情况:
- 酶抑制是一种常见的药物开发策略.
- 小分子诱导的蛋白质降解是一种新兴的治疗方法.
- 焦点粘附激酶 (FAK) 在瘤进展中至关重要,它既起着激酶的作用,又起着支架的作用.
研究的目的:
- 通过蛋白质降解开发针对FAK的新疗法.
- 与传统抑制剂相比,评估一种新的FAK降解剂PROTAC-3的疗效.
主要方法:
- 开发一种选择性FAK降解剂 (PROTAC-3).
- 将PROTAC-3与临床FAK抑制剂 (defactinib) 的比较
- 对FAK活动,细胞迁移和侵入抑制的评估.
主要成果:
- 证明PROTAC-3具有强大和选择性的FAK降解.
- 在抑制FAK介导细胞迁移和侵入方面,PROTAC-3的表现优于defactinib.
- PROTAC-3有效地阻断了FAK的激酶信号和支架功能.
结论:
- PROTAC-3 是针对FAK的一种有前途的治疗药物.
- PROTACs提供了一种可行的策略来解决传统抑制剂难以调节的目标.
- 针对FAK降解扩大了癌症治疗的治疗选择.
更多相关视频
05:33High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
12:46Bromodeoxyuridine BrdU Labeling and Subsequent Fluorescence Activated Cell Sorting for Culture-independent Identification of Dissolved Organic Carbon-degrading Bacterioplankton
Published on: September 10, 2011
相关概念视频
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Proteins: From Genes to Degradation
Transcription is the synthesis of RNA...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Introduction to Test of Independence
The test statistic for a test of independence is similar to that of a goodness-of-fit test:
Hypothesis Test for Test of Independence
H0: The two variables (factors)...
